EssilorLuxottica Reports Recent Share Capital and Voting Rights

Understanding EssilorLuxottica's Share Capital and Voting Rights
As one of the leading companies in the optical and eyewear industry, EssilorLuxottica plays a significant role in the global market for lenses, frames, and sunglasses. In this disclosure, we will delve into the details of the share capital and voting rights outstanding as of a recent date.
Current Standing of Shares Outstanding
According to the latest report, as of July 31, shares outstanding for EssilorLuxottica are listed as follows:
Share Count Breakdown
EssilorLuxottica has a total of 463,145,529 shares outstanding. This figure is essential for understanding the company’s market position and allows investors to gauge the equity available.
Voting Rights Information
Additionally, the number of voting rights that real shareholders possess, excluding treasury shares, amounts to 461,156,230. This number is significant as it reflects the actual power shareholders have in influencing the company’s decisions.
Theoretical Voting Rights
When including treasury shares, the theoretical total of voting rights equals the number of shares outstanding, which also stands at 463,145,529. This metric helps assess the overall voting potential of the company's shareholders.
Understanding Voting Rights Limitation
One crucial aspect to highlight is that voting rights are limited to a cap of 31% for any single shareholder. This restriction aims to maintain balanced governance and prevent any one shareholder from dominating the decision-making processes.
Governance Overview
For those interested in deeper governance structures, EssilorLuxottica’s by-laws provide detailed insight into these regulations and are accessible on the company’s official governance publications section.
Conclusion
To sum up, EssilorLuxottica, under the ticker Paris:EL, continues to showcase its significant presence in the eyewear and optical market through transparency in reporting its share capital and voting rights. Understanding these metrics is essential for current and potential investors looking to make informed decisions in this dynamic industry.
Frequently Asked Questions
What is the total number of shares outstanding for EssilorLuxottica?
EssilorLuxottica has 463,145,529 shares outstanding.
How many actual voting rights do shareholders possess?
The company has 461,156,230 real voting rights available to shareholders, excluding treasury shares.
What is the theoretical number of voting rights including treasury shares?
The theoretical number of voting rights, including treasury shares, is also 463,145,529.
What is the cap on voting rights for EssilorLuxottica?
Voting rights are capped at 31% for any single shareholder, according to the company's by-laws.
Where can I find more information about EssilorLuxottica’s governance structure?
Detailed governance information including the by-laws can be found on EssilorLuxottica's official website under the governance publications section.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.